Bill

Bill > S3932


NJ S3932

NJ S3932
Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.


summary

Introduced
12/09/2024
In Committee
05/12/2025
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.

AI Summary

This bill requires New Jersey Transit (NJT) to establish a two-year pilot program to provide opioid antidotes on light rail train sets in the southern part of the state. The bill defines key terms such as "opioid antidote" (a medication like naloxone used to reverse opioid overdoses) and "train set" (a locomotive and accompanying railcars). Under the program, NJT must distribute opioid antidotes to every light rail train set, store them in secure, easily accessible locations that trigger a silent alert to the train operator when opened, and ensure at least two doses are available on each train. The train sets must also be marked with signs in English and Spanish explaining how to recognize and respond to an overdose. While train operators will be required to contact emergency services if an overdose is detected, staff members will not be required to administer the antidote or receive specialized training. After the two-year pilot program, NJT must submit a report to the Governor and Legislature evaluating the program's effectiveness and recommending whether to implement it statewide. The bill includes a $100,000 appropriation from the General Fund to cover implementation costs and will take effect six months after enactment, expiring after the report is submitted.

Committee Categories

Budget and Finance, Transportation and Infrastructure

Sponsors (2)

Last Action

Referred to Senate Budget and Appropriations Committee (on 05/12/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...